Connect
MJA
MJA

Lifestyle modifiable reproductive and metabolic disease in women

Helena J Teede, Anju Joham, Cheryce L Harrison and Jacqueline A Boyle
Med J Aust 2016; 205 (8): . || doi: 10.5694/mja16.00891
Published online: 17 October 2016

A major public health concern and prevention opportunity

Diet and physical activity have profound health impacts across the lifespan. Weight is escalating with reduced physical activity and increased caloric intake. Obesity now causes more ill health than undernutrition and it is driving non-communicable diseases internationally.1 Young women have the highest rate of weight gain, with unprecedented reproductive health implications. Metabolic, mental health and musculoskeletal complications are all increased in obesity, as is malignancy. The greatest effects fall increasingly on low and middle income countries, and on poorer people within all countries, mirroring the underlying socio-economic determinants.1 In Australia, Aboriginal and Torres Strait Islander women present a key risk group. With established obesity being exceedingly difficult to treat, public health obesity prevention initiatives are now prioritised internationally. These initiatives need to be population wide and we align with the National Health and Medical Research Council (NHMRC) Obesity Case for Action and propose that young women of reproductive age, especially those of low socio-economic status and of Aboriginal and Torres Strait Islander background, are an important target group for obesity prevention.


  • 1 Monash Partners Academic Health Sciences Centre, Monash University, Melbourne, VIC
  • 2 Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC


Correspondence: helena.teede@monash.edu

Acknowledgements: 

Helena Teede is an NHMRC-funded practitioner fellow. Anju Joham is an NHMRC-funded early career fellow and Cheryce Harrison is a National Heart Foundation-funded fellow. Jacqueline Boyle is funded by the NHMRC Centre for Research Excellence fellowship.

Competing interests:

No relevant disclosures.

  • 1. Alwan A, Armstrong T, Bettcher D, et al. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
  • 2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781.
  • 3. Women’s Health Australia. Australian Women and their weight — a growing problem. Australian Longitudinal Study on Women’s Health series. Australian Government Department of Health and Ageing; 2005 http://www.alswh.org.au/images/content/pdf/achievement_reports/achievements-weight.pdf (accessed Feb 2008).
  • 4. Australian Bureau of Statistics [website]. Australian Aboriginal and Torres Strait Islander health survey: updated results, 2012–13 (ABS Cat. No. 4727.0.55.006). Canberra: ABS; 2014. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4727.0.55.006∼2012%E2%80%9313∼Main%20Features∼Tobacco%20smoking∼13 (accessed Aug 2016).
  • 5. Zhang HY, Guo CX, Zhu FF, et al. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet 2013; 287: 525-531.
  • 6. Black KI, Gordon A. Obesity before pregnancy: new evidence and future strategies. Med J Aust 2016; 205: 152-154. <MJA full text>
  • 7. Malnick SD, Knobler H. The medical complications of obesity. QJM 2006; 99: 565-579.
  • 8. Teede HJ, Misso ML, Deeks AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195: 65. <MJA full text>
  • 9. Hayes MG, Urbanek M, Ehrmann DA, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun 2015; 6: 7502.
  • 10. Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS). Endocr Rev 2016; doi: 10.1210/er.2015-1104 [Epub ahead of print].
  • 11. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16: 347-363.
  • 12. Brewer CJ, Balen AH. The adverse effects of obesity on conception and implantation. Reproduction 2010; 140: 347-364.
  • 13. Provost MP, Acharya KS, Acharya CR, et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239 127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry. Fertil Steril 2016; 105: 663-669.
  • 14. Mutsaerts MAQ, van Oers AM, Groen H, et al. Randomized trial of a lifestyle program in obese infertile women. N Engl J Med 2016; 374: 1942-1953.
  • 15. Legro RS, Dodson WC, Kris-Etherton PM, et al. Randomized controlled trial of preconception interventions in infertile women with polycystic ovary syndrome. J Clin Endocrinol Metab 2015; 100: 4048-4058.
  • 16. Teede H, Harrison C, Lombard C, et al. Case for Action — proposal to NHMRC: obesity prevention through preventing excess weight gain during pregnancy and postpartum. Canberra: National Health and Medical Research Council; 2015. https://www.nhmrc.gov.au/_files_nhmrc/file/research/research_translation_faculty/rtf_cfa_obesity_nhmrc_150320.pdf (accessed Aug 2016).
  • 17. Dodd JM, Grivell RM, Nguyen AM, et al. Maternal and perinatal health outcomes by body mass index category. Aust N Z J Obstet Gynaecol 2011; 51: 136-140.
  • 18. Thangaratinam S, Rogozińska E, Jolly K. et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 2012; 344: e2088.
  • 19. Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
  • 20. O’Dea K, Cunningham J, Maple-Brown L, et al. Diabetes and cardiovascular risk factors in urban Indigenous adults: results from the DRUID study. Diabetes Res Clin Practice 2008; 80: 483-489.
  • 21. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ 2007; 334: 299.
  • 22. Schutte AE, Shemesh T, Rowley K, et al. The metabolic syndrome and changing relationship between blood pressure and insulin with age, as observed in Aboriginal and Torres Strait Islander peoples. Diabet Med 2005; 22: 1589-1597.
  • 23. Cameron AJ, Magliano DJ, Zimmet PZ, et al. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007; 77: 471-478.
  • 24. Australian Institute of Health and Welfare. Women and heart disease: cardiovascular profile of women in Australia (AIHW Cat. No. CVD 49). Canberra: AIHW; 2010. http://www.aihw.gov.au/publication-detail/?id=6442468369 (accessed Aug 2016).
  • 25. Campbell KJ, Crawford DA, Ball K. Family food environment and dietary behaviors likely to promote fatness in 5–6 year-old children. Int J Obes (Lond) 2006; 30: 1272-1280.
  • 26. Cameron AJ, Crawford DA, Salmon J, et al. Clustering of obesity-related risk behaviors in children and their mothers. Ann Epidemiol 2011; 21: 95-102.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.